Literature DB >> 21225309

The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study.

Kosuke Kudo1, Tsuneo Konta, Yusuke Mashima, Kazunobu Ichikawa, Satoshi Takasaki, Ami Ikeda, Masato Hoshikawa, Kazuko Suzuki, Yoko Shibata, Tetsu Watanabe, Takeo Kato, Sumio Kawata, Isao Kubota.   

Abstract

BACKGROUND: Injury to renal tubules plays an important role in the development of various renal diseases; however, the prevalence and significance of renal tubular damage in the general population are unclear. To clarify this point, we conducted a community-based study, using urinary β(2)-microglobulin as a marker of tubular damage.
METHODS: The subjects studied were 3,444 Japanese over the age of 40 years. The urinary β(2)-microglobulin-creatinine ratio (UBCR) was assessed in morning spot urine samples.
RESULTS: In this population, the distribution of the UBCR among these subjects was skewed towards higher values and a high UBCR (≥300 μg/g) was identified in 438 (12.7%) subjects. However, overlap with macroalbuminuria and renal insufficiency [estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2)] was observed in only 25 (5.7%) and 58 (13.2%) of these subjects, respectively. Multivariate analysis indicated that a high UBCR was positively associated with aging, hypertension, macroalbuminuria and increased urinary sodium excretion. A 5-year longitudinal analysis in 899 subjects indicated a greater decline in eGFR in parallel with the increase in baseline UBCR. After adjustment for possible confounders, a high UBCR was an independent risk factor for rapid decline in eGFR [<-10 mL/min/1.73 m(2); odds ratio 1.79 (95% confidence interval 1.07-2.99), P = 0.026].
CONCLUSION: This study showed that renal tubular damage was common and was an independent risk factor for renal deterioration in the Japanese population. More attention should be paid to occult renal tubular damage in order to prevent end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225309     DOI: 10.1007/s10157-010-0392-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  18 in total

1.  A fifteen year cohort based evaluation of beta 2-microglobulin as an early sign of Balkan endemic nephropathy.

Authors:  A Hrabar; B Aleraj; S Ceović; D Cvoriscec; C Vacca; P W Hall
Journal:  Kidney Int Suppl       Date:  1991-11       Impact factor: 10.545

2.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.

Authors:  T Konta; Z Hao; H Abiko; M Ishikawa; T Takahashi; A Ikeda; K Ichikawa; S Takasaki; I Kubota
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

Review 3.  Microalbuminuria and essential hypertension: renal and cardiovascular implications.

Authors:  F C Luft
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-11       Impact factor: 2.894

4.  Microalbuminuria in urban Zimbabwean women.

Authors:  K K Hwang; L J Scott; J Chifamba; J Mufunda; W S Spielman; H V Sparks
Journal:  J Hum Hypertens       Date:  2000-09       Impact factor: 3.012

5.  Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment.

Authors:  M Nishijo; Y Morikawa; H Nakagawa; K Tawara; K Miura; T Kido; A Ikawa; E Kobayashi; K Nogawa
Journal:  Occup Environ Med       Date:  2006-04-06       Impact factor: 4.402

6.  Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications.

Authors:  Walter G Guder; Walter Hofmann
Journal:  Scand J Clin Lab Invest Suppl       Date:  2008

Review 7.  Biomarkers in acute and chronic kidney disease.

Authors:  Thomas L Nickolas; Jonathan Barasch; Prasad Devarajan
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-03       Impact factor: 2.894

8.  Urinary excretion of albumin and beta 2-microglobulin in a population from an area where Balkan nephropathy is endemic.

Authors:  F A Karlsson; R Lenkei
Journal:  Scand J Clin Lab Invest       Date:  1977-04       Impact factor: 1.713

9.  In a non-diabetic Japanese population, the combination of macroalbuminuria and increased urine beta 2-microglobulin predicts a decline of renal function: the Takahata study.

Authors:  Ami Ikeda; Tsuneo Konta; Satoshi Takasaki; Zhimei Hao; Kazuko Suzuki; Hitoshi Sato; Yoko Shibata; Yasuchika Takeishi; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  Nephrol Dial Transplant       Date:  2008-10-30       Impact factor: 5.992

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  11 in total

1.  Validity of predictive equations for 24-h urinary potassium excretion based on timing of spot urine collection among adults: the MESA and CARDIA Urinary Sodium Study and NHANES Urinary Sodium Calibration Study.

Authors:  Carla I Mercado; Mary E Cogswell; Catherine M Loria; Kiang Liu; Norrina Allen; Cathleen Gillespie; Chia-Yih Wang; Ian H de Boer; Jacqueline Wright
Journal:  Am J Clin Nutr       Date:  2018-09-01       Impact factor: 7.045

2.  Relationship between dietary intake and microalbuminuria: findings from the Takahata study.

Authors:  Masahiro Sato; Atsushi Hozawa; Tsuneo Konta; Li Shao; Katsumi Otani; Hiroto Narimatsu; Satoshi Sasaki; Takeo Kato; Isao Kubota; Hidetoshi Yamashita; Takamasa Kayama; Akira Fukao
Journal:  Clin Exp Nephrol       Date:  2011-10-04       Impact factor: 2.801

3.  Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Hiroki Takahashi; Akira Funayama; Daisuke Kinoshita; Miyuki Yokoyama; Tetsuya Takahashi; Satoshi Nishiyama; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Tsuneo Konta; Isao Kubota
Journal:  Clin Res Cardiol       Date:  2015-07-29       Impact factor: 5.460

4.  The association between serum uric acid and renal damage in a community-based population: the Takahata study.

Authors:  Kazuko Suzuki; Tsuneo Konta; Kosuke Kudo; Hiroko Sato; Ami Ikeda; Kazunobu Ichikawa; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2012-11-27       Impact factor: 2.801

Review 5.  Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities.

Authors:  Mary E Cogswell; Joyce Maalouf; Paul Elliott; Catherine M Loria; Sheena Patel; Barbara A Bowman
Journal:  Annu Rev Nutr       Date:  2015-05-06       Impact factor: 11.848

6.  Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas.

Authors:  Yihuai Liang; Lijian Lei; Johan Nilsson; Huiqi Li; Monica Nordberg; Alfred Bernard; Gunnar F Nordberg; Ingvar A Bergdahl; Taiyi Jin
Journal:  Environ Health Perspect       Date:  2011-10-25       Impact factor: 9.031

7.  Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial.

Authors:  Takeshi Nishijima; Hiroyuki Gatanaga; Takuro Shimbo; Hirokazu Komatsu; Tomoyuki Endo; Masahide Horiba; Michiko Koga; Toshio Naito; Ichiro Itoda; Masanori Tei; Teruhisa Fujii; Kiyonori Takada; Masahiro Yamamoto; Toshikazu Miyakawa; Yoshinari Tanabe; Hiroaki Mitsuya; Shinichi Oka
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

Review 8.  Dietary Cadmium Intake and Its Effects on Kidneys.

Authors:  Soisungwan Satarug
Journal:  Toxics       Date:  2018-03-10

9.  Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

Authors:  Frank A Post; Pablo Tebas; Amanda Clarke; Laurent Cotte; William R Short; Michael E Abram; Shuping Jiang; Andrew Cheng; Moupali Das; Marshall W Fordyce
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

10.  Urinary Cadmium Threshold to Prevent Kidney Disease Development.

Authors:  Soisungwan Satarug; Werawan Ruangyuttikarn; Muneko Nishijo; Patricia Ruiz
Journal:  Toxics       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.